Clinical Trial Update: A Non-randomised, Non-inferiority Comparative Study of Oral Actiskenan (Morphine Sulfate) Versus Intranasal Sufentanil in the Early Management of Severe Acute Pain in Emergency Departments.

View source ↗

Summary

This clinical trial registry entry describes a non-randomised, non-inferiority study comparing oral morphine sulfate (Actiskenan) with intranasal sufentanil for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Actiskenan (Morphine sulfate)
• Sufentanil (intranasal) (sufentanil)

Snippet

Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace | Conditions: Severe Acute Pain | Status: NOT_YET_RECRUITING